Ophthalmology Therapeutics: Does current pipeline innovation hold the potential to affect the future ophthalmology market?

This Frontier Pharma: Ophthalmology Therapeutics assesses first-in-class innovation in the ophthalmology pipeline, highlighting key trends in the distribution of these products.

Pune, India - March 14, 2018 /MarketersMedia/ —

The pipeline is varied in terms of molecular targets and molecule types. Products acting on the immune system and neurotransmitter signaling are the most prevalent, but no single target dominates by any clear margin. There are a total of 194 first-in class pipeline products in development for ophthalmologic indications 38% of the 512 pipeline products for which there is a disclosed molecular target. Encompassing gene therapies, slowing of the visual cycle and antisense therapies, the pipeline appears robust and has huge potential to strengthen treatment options for ophthalmological disorders.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs

Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of disease pathogenesis, diagnosis and prognosis, and the treatment options available.
• Visualize the composition of the ophthalmological disorders market in terms of dominant molecule types and targets, and understand the current unmet needs and how they can be addressed. This knowledge allows a competitive understanding of gaps in the market.
• Analyze the ophthalmological disorders pipeline and stratify by stage of development, molecule type and molecular target. There are strong signs in the pipeline that the industry is seeking novel approaches to treating ophthalmological disorders to overcome the overwhelming level of unmet need.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising early-stage targets have been reviewed in greater detail.
• Identify commercial opportunities in the ophthalmological disorders deals landscape by analyzing trends in licensing and co-development deals, and a curated list of ophthalmological disorder therapies that have not yet been involved in deals, and may offer potential investment opportunities.

Get this report at: https://www.themarketreports.com/report/buy-now/935550

In the past the ophthalmological disorders therapy area has suffered from a lack of full understanding of the pathophysiology and underlying mechanisms of the diseases. However, as this knowledge has improved vastly in recent years, potential targets have been identified for treatment. As well as the main disorders previously mentioned, there is also interest in developing treatments for indications such as allergic conjunctivitis and retinitis pigmentosa. The approval of a gene therapy for retinitis pigmentosa is indicative of this progress, and represents the first gene therapy approved for an inherited condition by the FDA.

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935550

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/ophthalmology-therapeutics-does-current-pipeline-innovation-hold-the-potential-to-affect-the-future-ophthalmology-market/314326

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs%20%20

Source: MarketersMedia

Release ID: 314326

Latest News

Cubs sweep Padres with 7-4 win

Jul 16, 2018

SAN DIEGO — Jon Lester and the Chicago Cubs are on top of the National League at the All-Star break. Lester won for the eighth time in nine starts, Jason Heyward drove in two runs and the Cubs beat the sloppy San Diego Padres 7-4 on Sunday for a three-game series sweep. Chicago closed out a 4-2 West Coast trip. With All-Star second baseman Javier Baez putting together a big first half, the Cubs (55-38) lead the Milwaukee Brewers by 2 1/2 games in the NL Central. "I feel like we've been playing really good baseball for a while and...

Dozier's grand slam in 10th gives Twins 11-7 win over Rays

Jul 16, 2018

MINNEAPOLIS — Brian Dozier wrapped up a wild back-and-forth finish with the game-winning grand slam for Minnesota. After 3½ months of setbacks and slumps, the Twins finally have some momentum heading into the All-Star break. Dozier drove in five runs for the Twins, including the slam in the 10th inning on Sunday that delivered an 11-7 victory over the Tampa Bay Rays. "We're playing good baseball. We all need a break," Dozier said. "But I think hopefully we can pick up where we left off." Jake Cave doubled to start the 10th against Matt Andriese (2-4), the ninth pitcher for...

Sports betting no easy fix for U.S. gaming's most beleaguered industries

Jul 16, 2018

By Laila KearneyCLEVELAND (Reuters) - Long-struggling U.S. gambling industries hope to cash in on newly legal sports betting, but the growing wave of electronic and mobile gaming choices is considered more likely to change the face of those businesses rather than revive them.State lawmakers and gaming company officials meeting over the weekend in Cleveland offered sober assessments when discussing how sports betting and other emerging games could boost states' "sin taxes" and stimulate a sluggish gaming industry.“Nobody’s going to be able to tell you there’s a silver bullet to fix racing, but I think there are a lot of things...

Singh tops Maggert in playoff at Senior Players Championship

Jul 16, 2018

HIGHLAND PARK, Ill. — Vijay Singh hit a perfect approach to set up the winning playoff birdie. His celebration as the ball rolled into the cup was nowhere near as spectacular. Singh closed the door on Jeff Maggert on the second playoff hole to win the Constellation Senior Players Championship on Sunday, giving an understated fist pump as his birdie putt dropped from about 2 feet. It was the first major title on the PGA Tour Champions for the 55-year-old Fijian, a past winner of the Masters and two PGA Championships. "It's a little different," Singh said. "It's a senior...

Hernandez hits Dodgers' 129th homer in 5-3 win over Angels

Jul 16, 2018

LOS ANGELES — Clayton Kershaw has returned to form since coming off the disabled list and the Los Angeles Dodgers are leading the NL West after a disappointing start to the season. They can't wait for the second half. "Now it's kind of a sprint to the finish," Kershaw said. "We like where we're at." The Dodgers (53-43) closed the first half by rallying for a 5-3 win over the Angels on Sunday and head into the All-Star break leading Arizona by a half-game. "We're playing a little bit more now what we are. I don't think we're a 16-26...

About Us

The Final Scoreboard has fast, accurate live scores for you. We provide premium online content from in-depth analysis to the scores and statistics across American and European Sports.

Contact us: sales[at]thefinalscoreboard.com

Subscribe Now!